Share

Stem Disc 2

Towards intervertebral disc regeneration: mesenchymal stem/stromal cells with a novel bioactive hydrogel based approach

Project objectives

The ultimate goal of the project is to bring a therapy based on the use of bone marrow mesenchymal stem cells (MSC) associated with a bioactive hydrogel, from the animal model to clinical translation.

  • Objective 1: to develop a new injectable biomaterial functionalized with autologous chondrogenic factors (ACF) with properties and characteristics that allow immediate clinical use.
  • Objective 2: To test MSC/hydrogel transplantation for disc regeneration in a preclinical large animal model with the evaluation of the ideal cell dose and to optimize the protocol to achieve IMPD (Investigational Medicinal Product Dossier) for subsequent clinical translation.

Start and end date

23/11/2012 - 23/11/2016

Project managers

Dr. Gianluca Vadalà

Coordinating institution of the project

General Hospital, IRCCS Ca' Granda Foundation - Milan

Other Institutions involved in the project

  • University of Padua, Department of Animal Medicine, Production and Health
  • Musculoskeletal Regeneration Program, AO Research Institute - Davos, Switzerland

Funding source

Call for Young Researchers/Finalized Research, Ministry of Health

 

magnifiercrossmenuchevron-downchevron-leftchevron-right